annual current liabilities:
$3.94B+$520.90M(+15.22%)Summary
- As of today (June 29, 2025), REGN annual total current liabilities is $3.94 billion, with the most recent change of +$520.90 million (+15.22%) on December 31, 2024.
- During the last 3 years, REGN annual current liabilities has risen by +$11.80 million (+0.30%).
- REGN annual current liabilities is now at all-time high.
Performance
REGN Current liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly current liabilities:
$3.57B-$377.70M(-9.58%)Summary
- As of today (June 29, 2025), REGN quarterly total current liabilities is $3.57 billion, with the most recent change of -$377.70 million (-9.58%) on March 31, 2025.
- Over the past year, REGN quarterly current liabilities has dropped by -$14.30 million (-0.40%).
- REGN quarterly current liabilities is now -9.58% below its all-time high of $3.94 billion, reached on December 31, 2024.
Performance
REGN quarterly current liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Current liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
REGN Current liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +15.2% | -0.4% |
| 3 y3 years | +0.3% | +18.6% |
| 5 y5 years | +88.1% | +73.5% |
REGN Current liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +25.6% | -9.6% | +23.9% |
| 5 y | 5-year | at high | +88.1% | -9.6% | +73.5% |
| alltime | all time | at high | >+9999.0% | -9.6% | >+9999.0% |
REGN Current liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $3.57B(-9.6%) |
| Dec 2024 | $3.94B(+15.2%) | $3.94B(+7.7%) |
| Sep 2024 | - | $3.66B(+4.3%) |
| Jun 2024 | - | $3.51B(-2.0%) |
| Mar 2024 | - | $3.58B(+4.6%) |
| Dec 2023 | $3.42B(+9.0%) | $3.42B(-4.9%) |
| Sep 2023 | - | $3.60B(+15.9%) |
| Jun 2023 | - | $3.10B(+0.1%) |
| Mar 2023 | - | $3.10B(-1.3%) |
| Dec 2022 | $3.14B(-20.1%) | $3.14B(+9.1%) |
| Sep 2022 | - | $2.88B(-5.1%) |
| Jun 2022 | - | $3.03B(+0.9%) |
| Mar 2022 | - | $3.01B(-23.5%) |
| Dec 2021 | $3.93B(+45.8%) | $3.93B(+5.9%) |
| Sep 2021 | - | $3.71B(-0.5%) |
| Jun 2021 | - | $3.73B(+16.0%) |
| Mar 2021 | - | $3.22B(+19.3%) |
| Dec 2020 | $2.70B(+28.7%) | $2.70B(+15.4%) |
| Sep 2020 | - | $2.34B(-36.9%) |
| Jun 2020 | - | $3.70B(+80.1%) |
| Mar 2020 | - | $2.06B(-2.0%) |
| Dec 2019 | $2.10B(+45.3%) | $2.10B(+18.8%) |
| Sep 2019 | - | $1.77B(+3.1%) |
| Jun 2019 | - | $1.71B(+13.3%) |
| Mar 2019 | - | $1.51B(+4.8%) |
| Dec 2018 | $1.44B(+27.1%) | $1.44B(+1.8%) |
| Sep 2018 | - | $1.42B(+6.5%) |
| Jun 2018 | - | $1.33B(+5.2%) |
| Mar 2018 | - | $1.27B(+11.5%) |
| Dec 2017 | $1.14B(-8.5%) | $1.14B(-0.3%) |
| Sep 2017 | - | $1.14B(+10.7%) |
| Jun 2017 | - | $1.03B(-21.3%) |
| Mar 2017 | - | $1.31B(+5.4%) |
| Dec 2016 | $1.24B(+53.1%) | $1.24B(+29.2%) |
| Sep 2016 | - | $961.18M(+1.0%) |
| Jun 2016 | - | $951.56M(+3.5%) |
| Mar 2016 | - | $919.72M(+13.4%) |
| Dec 2015 | $811.16M(+23.9%) | $811.16M(+10.4%) |
| Sep 2015 | - | $734.99M(+22.2%) |
| Jun 2015 | - | $601.54M(+12.2%) |
| Mar 2015 | - | $536.13M(-18.1%) |
| Dec 2014 | $654.66M(+119.1%) | $654.66M(+59.6%) |
| Sep 2014 | - | $410.20M(+16.7%) |
| Jun 2014 | - | $351.58M(+15.2%) |
| Mar 2014 | - | $305.07M(+2.1%) |
| Dec 2013 | $298.83M(+82.7%) | $298.83M(+11.2%) |
| Sep 2013 | - | $268.73M(+31.9%) |
| Jun 2013 | - | $203.80M(+3.3%) |
| Mar 2013 | - | $197.24M(+20.6%) |
| Dec 2012 | $163.55M(+10.3%) | $163.55M(-8.4%) |
| Sep 2012 | - | $178.57M(-2.5%) |
| Jun 2012 | - | $183.22M(+14.2%) |
| Mar 2012 | - | $160.39M(+8.2%) |
| Dec 2011 | $148.27M(+36.0%) | $148.27M(+11.3%) |
| Sep 2011 | - | $133.24M(-1.9%) |
| Jun 2011 | - | $135.87M(+21.0%) |
| Mar 2011 | - | $112.25M(+2.9%) |
| Dec 2010 | $109.06M(+16.5%) | $109.06M(-18.5%) |
| Sep 2010 | - | $133.83M(+11.9%) |
| Jun 2010 | - | $119.57M(+14.9%) |
| Mar 2010 | - | $104.09M(+11.2%) |
| Dec 2009 | $93.58M(+11.8%) | $93.58M(-18.0%) |
| Sep 2009 | - | $114.17M(-5.2%) |
| Jun 2009 | - | $120.42M(+16.8%) |
| Mar 2009 | - | $103.11M(+23.2%) |
| Dec 2008 | $83.67M | $83.67M(-61.6%) |
| Sep 2008 | - | $217.77M(-2.7%) |
| Jun 2008 | - | $223.92M(-21.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2008 | - | $285.95M(+0.8%) |
| Dec 2007 | $283.66M(+530.2%) | $283.66M(+193.4%) |
| Sep 2007 | - | $96.69M(-7.8%) |
| Jun 2007 | - | $104.83M(+25.4%) |
| Mar 2007 | - | $83.60M(+85.7%) |
| Dec 2006 | $45.01M(+11.5%) | $45.01M(+37.7%) |
| Sep 2006 | - | $32.70M(+3.8%) |
| Jun 2006 | - | $31.51M(-6.4%) |
| Mar 2006 | - | $33.67M(-16.6%) |
| Dec 2005 | $40.36M(+18.2%) | $40.36M(+20.4%) |
| Sep 2005 | - | $33.52M(+11.9%) |
| Jun 2005 | - | $29.95M(+0.1%) |
| Mar 2005 | - | $29.93M(-12.3%) |
| Dec 2004 | $34.14M(-53.2%) | $34.14M(-4.9%) |
| Sep 2004 | - | $35.90M(-3.9%) |
| Jun 2004 | - | $37.37M(+2.9%) |
| Mar 2004 | - | $36.34M(-50.2%) |
| Dec 2003 | $72.92M(+81.8%) | $72.92M(+33.2%) |
| Sep 2003 | - | $54.74M(+11.6%) |
| Jun 2003 | - | $49.06M(-17.4%) |
| Mar 2003 | - | $59.37M(+48.0%) |
| Dec 2002 | $40.12M(+82.2%) | $40.12M(+22.9%) |
| Sep 2002 | - | $32.65M(+52.0%) |
| Jun 2002 | - | $21.48M(-6.4%) |
| Mar 2002 | - | $22.94M(+4.2%) |
| Dec 2001 | $22.02M(+59.7%) | $22.02M(+52.8%) |
| Sep 2001 | - | $14.41M(+11.5%) |
| Jun 2001 | - | $12.93M(-6.7%) |
| Mar 2001 | - | $13.86M(+0.5%) |
| Dec 2000 | $13.79M(+3.7%) | $13.79M(+8.2%) |
| Sep 2000 | - | $12.74M(-2.2%) |
| Jun 2000 | - | $13.03M(+4.6%) |
| Mar 2000 | - | $12.45M(-6.4%) |
| Dec 1999 | $13.30M(+41.5%) | $13.30M(+49.4%) |
| Sep 1999 | - | $8.90M(+2.3%) |
| Jun 1999 | - | $8.70M(-12.1%) |
| Mar 1999 | - | $9.90M(+5.3%) |
| Dec 1998 | $9.40M(-12.1%) | $9.40M(-2.1%) |
| Sep 1998 | - | $9.60M(+12.9%) |
| Jun 1998 | - | $8.50M(+13.3%) |
| Mar 1998 | - | $7.50M(-29.9%) |
| Dec 1997 | $10.70M(-10.8%) | $10.70M(+37.2%) |
| Sep 1997 | - | $7.80M(-27.8%) |
| Jun 1997 | - | $10.80M(+11.3%) |
| Mar 1997 | - | $9.70M(-19.2%) |
| Dec 1996 | $12.00M(-7.0%) | $12.00M(+34.8%) |
| Sep 1996 | - | $8.90M(-7.3%) |
| Jun 1996 | - | $9.60M(-8.6%) |
| Mar 1996 | - | $10.50M(-18.6%) |
| Dec 1995 | $12.90M(-27.9%) | $12.90M(-8.5%) |
| Sep 1995 | - | $14.10M(-13.0%) |
| Jun 1995 | - | $16.20M(+18.2%) |
| Mar 1995 | - | $13.70M(-23.5%) |
| Dec 1994 | $17.90M(+36.6%) | $17.90M(+8.5%) |
| Sep 1994 | - | $16.50M(-24.0%) |
| Jun 1994 | - | $21.70M(+97.3%) |
| Mar 1994 | - | $11.00M(-16.0%) |
| Dec 1993 | $13.10M(+184.8%) | $13.10M(+39.4%) |
| Sep 1993 | - | $9.40M(+27.0%) |
| Jun 1993 | - | $7.40M(+19.4%) |
| Mar 1993 | - | $6.20M(+34.8%) |
| Dec 1992 | $4.60M(+39.4%) | $4.60M(-13.2%) |
| Sep 1992 | - | $5.30M(+26.2%) |
| Jun 1992 | - | $4.20M(+5.0%) |
| Mar 1992 | - | $4.00M(+21.2%) |
| Dec 1991 | $3.30M(+83.3%) | $3.30M(+57.1%) |
| Sep 1991 | - | $2.10M(+5.0%) |
| Jun 1991 | - | $2.00M(+11.1%) |
| Dec 1990 | $1.80M | $1.80M |
FAQ
- What is Regeneron Pharmaceuticals annual total current liabilities?
- What is the all time high annual current liabilities for Regeneron Pharmaceuticals?
- What is Regeneron Pharmaceuticals annual current liabilities year-on-year change?
- What is Regeneron Pharmaceuticals quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Regeneron Pharmaceuticals?
- What is Regeneron Pharmaceuticals quarterly current liabilities year-on-year change?
What is Regeneron Pharmaceuticals annual total current liabilities?
The current annual current liabilities of REGN is $3.94B
What is the all time high annual current liabilities for Regeneron Pharmaceuticals?
Regeneron Pharmaceuticals all-time high annual total current liabilities is $3.94B
What is Regeneron Pharmaceuticals annual current liabilities year-on-year change?
Over the past year, REGN annual total current liabilities has changed by +$520.90M (+15.22%)
What is Regeneron Pharmaceuticals quarterly total current liabilities?
The current quarterly current liabilities of REGN is $3.57B
What is the all time high quarterly current liabilities for Regeneron Pharmaceuticals?
Regeneron Pharmaceuticals all-time high quarterly total current liabilities is $3.94B
What is Regeneron Pharmaceuticals quarterly current liabilities year-on-year change?
Over the past year, REGN quarterly total current liabilities has changed by -$14.30M (-0.40%)